Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study
Clinical trial NCT01411150 · COMPLETED
Trial details
- NCT number
- NCT01411150
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2012-09-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.